More than 300 news organizations, including CBS and Forbes, quoted Abt’s Lauren Olsho explaining the benefits of our PROTECT study for the CDC, which gathers and tests nasal swabs weekly from children, regardless of whether they had COVID-19 symptoms. “Without regular weekly testing you will miss many infections, particularly for kids, who often have mild symptoms,” said Olsho, the study’s principal investigator. Other pediatric vaccine studies captured only symptomatic cases, and with more home testing, studies like Abt’s are needed for a comprehensive view of vaccine effectiveness, she noted.
Read More
COVID-19 in North America
Closing the Gap: Surveying LA Renters to Improve Housing Access
Abt helped HACLA collect and analyze current Los Angeles rental data, showing rents were about 12% higher than federal estimates and providing evidence to support voucher subsidy levels that better reflect local housing costs and improve access to stable housing.
Regulating Harmful Contaminants for Healthier Communities
Abt supported the EPA in developing and implementing data-driven regulations for hazardous chemicals—particularly carbon tetrachloride—helping turn scientific evidence into enforceable protections that reduce risks to workers, nearby communities, and the environment.
From Exposure to Protection: Securing Safe Drinking Water
Abt helped the EPA develop data-driven regulations, treatment tools, and exposure models that strengthen protections against contaminants such as PFAS and lead, improving drinking water safety for millions of Americans.
Stronghold Federal at VETS 2026
Meet Stronghold Federal at VETS26 and connect with our team at Booth 106 to discuss federal health, data, and mission delivery.